HBK Investments’s Regenxbio RGNX Stock Holding History

HBK Investments’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-21,169	Closed	-$888K	–	1301
2018 Q4	$888K	Buy	21,169 +229	+1%	+$13.4K	0.01%	724
2018 Q3	$1.58M	Buy	+20,940	New	+$1.51M	0.01%	591

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HBK Investments's RGNX Position: Q1 2019 in Review

HBK Investments sold out of Regenxbio (RGNX) in Q1 2019, closing a stake of 21,169 shares — an estimated $888K sold.

HBK Investments first reported a position in RGNX in Q3 2018 and held it in 2 quarters. The position peaked at $1.58M in Q3 2018. 211 funds tracked by Wall St. Rank hold RGNX as of Q1 2019.

HBK Investments reported no remaining Regenxbio position as of Q1 2019 after selling out during the quarter.
HBK Investments sold 21,169 Regenxbio shares in Q1 2019, an estimated $888K.
HBK Investments first reported a position in Regenxbio in Q3 2018 and held it in 2 quarters.
HBK Investments's Regenxbio position peaked at $1.58M in Q3 2018.
211 funds tracked by Wall St. Rank held Regenxbio as of Q1 2019.

Based on HBK Investments's 13F filing for Q1 2019, filed 15 May 2019.